Noxopharm Mid- Year Briefing May 2017
New Corporate Presentation
Discovery of Idronoxil-C - NOX CEO explains
FNN Interview with NOX CEO Explaining Idronoxil-C Discovery
ASX The CEO Sessions - ASX Interview
ASX The CEO Sessions February 2017 Presentation
ASX CEO Presentation Feb 2017 slides
Upcoming Events and Presentations
Noxopharm (ASX:NOX) talks clinical trials and applications for ‘NOX66’
November 2016 Corporate Presentation